EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The immunopharmacological role of B-cell and neutrophil-derived extracellular vesicles in pancreatic cancer: Mechanisms of inflammation, tumor progression, and potential therapeutic targets

Fatemeh Maher, Ali Samadi, Seyedeh Fatemeh Sajjadi, Sepideh Heydari, Jeffrey Gross, Ghazal Azimi

International Immunopharmacology · 2026-10 · 186 · 117102

DOI: 10.1016/j.intimp.2026.117102 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Fatemeh Maher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Islamic Azad University of Tehran, Tehran, Iran. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Extracellular Vesicles, Neutrophils, B-Lymphocytes. Die Arbeit nennt 249 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PC) is defined by a highly orchestrated immunosuppressive and inflammatory microenvironment. Recent evidence identifies immune-cell-derived Extracellular vesicles (EVs) as pivotal mediators of this intercellular crosstalk. This review provides an in-depth analysis of EVs derived from B-lymphocytes and neutrophils, focusing on their dualistic roles in PC progression. We systematically examine the molecular mechanisms of their biogenesis, emphasizing the influence of NF-κB and STAT3 signaling pathways on cargo selection, including specific miRNAs and proteins. The manuscript further explores how these EVs modulate the tumor microenvironment (TME) to promote desmoplasia and chemoresistance, while also evaluating their pharmacological potential as biomimetic nanocarriers for targeted therapy. By synthesizing recent clinical and preclinical data (up to 2025), this review highlights the dual nature of these vesicles as both drivers of malignancy and promising tools for personalized immunotherapy in pancreatic adenocarcinoma. Pancreatic ductal adenocarcinoma (PDAC) is characterized by its aggressive clinical course and a complex multifactorial etiology, including genetic predispositions like Lynch syndrome and metabolic drivers such as obesity and chronic pancreatitis. Beyond these systemic risk factors, the progression of PDAC is profoundly orchestrated by the tumor microenvironment (TME). Central to this orchestration are immune-derived EVs, which act as critical mediators of intercellular communication. These vesicles facilitate tumor progression by modulating immune evasion and shaping an immunosuppressive landscape. Consequently, understanding the molecular cargo of immune-derived EVs and their role in immune regulation presents a transformative frontier for developing targeted therapeutic strategies in PDAC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsExtracellular VesiclesNeutrophilsB-LymphocytesCarcinoma, Pancreatic DuctalHumansTumor MicroenvironmentAnimalsDisease ProgressionInflammationImmunotherapySignal Transduction

Stichwörter der Autor:innen

B-lymphocyte-derived extracellular vesiclesExtracellular vesicle cargo profilingImmune cell-derived nanovesiclesInflammation-driven tumorigenesisNeutrophil-mediated inflammatory SignalingPancreatic cancerTranslational nanomedicine approachesTumor microenvironment modulation

Autor:innen und Institutionen

  • Faculty of Pharmacy, Islamic Azad University of Tehran, Tehran, Iran.
  • Department of Basic Sciences, Faculty of Medicine, Bam University of Medical Sciences, Bam, Iran. Electronic address: alisamadi23@mubam.ac.ir.
  • School of Biological Science, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran.
  • Islamic Azad University, Science and Research Branch, Tehran, Iran.
  • ReCELLebrate Regenerative Medicine Clinic, Henderson, NV, USA.
  • Department of Nanobiomimetic, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.

Zitieren

APA

Maher, F., Samadi, A., Sajjadi, S. F., Heydari, S., Gross, J., & Azimi, G. (2026). The immunopharmacological role of B-cell and neutrophil-derived extracellular vesicles in pancreatic cancer: Mechanisms of inflammation, tumor progression, and potential therapeutic targets. International Immunopharmacology, 186, 117102. https://doi.org/10.1016/j.intimp.2026.117102

Vancouver

Maher F, Samadi A, Sajjadi SF, Heydari S, Gross J, Azimi G. The immunopharmacological role of B-cell and neutrophil-derived extracellular vesicles in pancreatic cancer: Mechanisms of inflammation, tumor progression, and potential therapeutic targets. International Immunopharmacology. 2026;186:117102. doi:10.1016/j.intimp.2026.117102

BibTeX
@article{Maher2026,
  author = {Maher, Fatemeh and Samadi, Ali and Sajjadi, Seyedeh Fatemeh and Heydari, Sepideh and Gross, Jeffrey and Azimi, Ghazal},
  title = {The immunopharmacological role of B-cell and neutrophil-derived extracellular vesicles in pancreatic cancer: Mechanisms of inflammation, tumor progression, and potential therapeutic targets},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {186},
  pages = {117102},
  doi = {10.1016/j.intimp.2026.117102}
}
Kostenlos starten →